ArticleJournal of the National Cancer Institute2013

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

Daniel Ajona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.